Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial

An Escherichia. coli-produced HPV-16/18 bivalent vaccine has been proved to be well-tolerated and highly efficacious against diseases associated with vaccine HPV types. As a part of the multi-center, randomized, double-blind phase III clinical trial, this lot-to-lot consistency study aimed to assess...

詳細記述

書誌詳細

主要な著者:	Ying-Ying Su, Bi-Zhen Lin, Hui Zhao, Juan Li, Zhi-Jie Lin, You-Lin Qiao, Li-Hui Wei, Yue-Mei Hu, Rong-Cheng Li, Si-Jie Zhuang, Guang Sun, Zi-Zheng Zheng, Shou-Jie Huang, Ting Wu, Jun Zhang, Hui-Rong Pan, Chang-Gui Li
フォーマット:	Artigo
言語:	Inglês
出版事項:	Taylor & Francis Group 2020-07-01
シリーズ:	Human Vaccines & Immunotherapeutics
主題:	human papillomavirus vaccine escherichia coli bivalent lot-to-lot consistency immunogenicity safety
オンライン･アクセス:	http://dx.doi.org/10.1080/21645515.2019.1691413
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!